Jump to Navigation
Trends and Sentiments
Comments and Analysis
Martin Marietta Materials (MLM) Q2 2015 Results -...
Juniper Pharmaceuticals' (JNP) CEO Frank Condella on...
Coach (COH) Victor Luis on Q4 2015 Results - Earnings...
AmeriGas Partners' (APU) CEO John Walsh on Q2 2015...
Factory Orders Rise 2nd Time in 11 Months, Led by...
comScore (SCOR) Serge Matta on Q2 2015 Results - Earnings...
Armada Hoffler Properties' (AHH) CEO Lou Haddad on...
New Chevy Volt drives way longer on a charge
Ctrip Shows No Signs Of Slowing Down
European shares hurt by disappointing earnings; Athens...
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
No, Rob Rhinehart, you can't save the planet...
George Osborne should not fear selling the state...
EUR/GBP: 1.4286 USD/EUR: 1.0902 JPY/USD: 124.2360
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions